PROCEPT BIOROBOTICS CORP reports a Return on Equity (ROE) of -29.47%.

What is PRCT's dividend yield?

PROCEPT BIOROBOTICS CORP offers a dividend yield of 0.00%.

What is PRCT's Quality Score?

Our AI rates PRCT's overall financial quality at 15 out of 100, based on profitability, growth, debt and earnings stability.

Is now a good time to buy PRCT?

Our AI Timing Score for PRCT is 28 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.

Which sector does PRCT belong to?

PROCEPT BIOROBOTICS CORP is classified under the Healthcare >> Medical Devices sector on the NASDAQ exchange

PRCT (NASDAQ) Stock Analysis | PROCEPT BIOROBOTICS CORP

Stock Check Daily update data at 8:30 AM
(Price: 2026-07-31 | FS: 2026-03-31)

PRCT AI Analysis Summary

Our AI summary for PRCT: PROCEPT BIOROBOTICS CORP (NASDAQ), Healthcare >> Medical Devices sector. The stock currently trades at a P/E of 0.00, ROE of -29.47%, a dividend yield of 0.00%. Its financial Quality Score stands at 15/100 — fundamentals below the market average. The AI Timing Score is 28/100 — most technical signals do not support an entry at this point. All scores are recomputed automatically after each market close from official exchange data. This is systematically generated analysis, not personalized investment advice.

PRCT

PROCEPT BIOROBOTICS CORP

US:NASDAQ STOCK Healthcare >> Medical Devices

USD 18.62

0.62 (3.44%) Day Change

Watchlist Portfolio Compare Chart

0.15

D/E

-29.5%

ROE

-21.0%

ROA

0.00%

Div Yield

PROCEPT BIOROBOTICS CORP
TYPE: STOCK
MARKET: NASDAQ

Compare Watchlist Myport

USD 18.62 Price 0.62 (3.44%) Day Change	NEWS SCORE: N/A

PRCT, the overall quality is not good ( Quality = 15) and the timing to buy is ...(Sign In to See)...

Loading chart...

15 QUALITY

Signal: UNDERPERFORM

Signal Description: Company financial health is Not Good

Reason: ROE is relatively low.
ROA is relatively low.
Acceleration of ROE growth rate is below our criteria.
Historical ROE is relatively low
Negative growth of ROE in the last year.
ROE is decreasing significantly
ROA is too relatively low compare to ROE
Acceleration of ROA growth rate is below our criteria.
Net profit margin is relatively low.
Acceleration of net profit margin growth rate is below our criteria
Historical net profit margin is relatively low.

88 Sign in

TIMING

Signal: OUTPERFORM

Signal Descri...: Good

Reason: Momentum indicators aligned on the daily timeframe

Unlock timing signals and detailed reasons

In details, quality factors are not good , financial health is not quite good , and ability to make profit is not quite good , ...

Quality Factors

39%

In Recommendations?	Not in any sections
Select Rate	0.00 From 30 days period
Watch Rate	0.00 From 30 days period
News Score	N/A
Magic Formula Rank by ROA	N/A
Magic Formula Rank by ROE	N/A
Magic Formula Rank by ROIC	N/A
Price	18.62
PBV / Sector	2.95 / -101.57
Earning Per Share	-1.86

PE / Sector	N/A / 31.23
PEG or PE/Growth / Sector	N/A / 0.40
Average 1M Daily Value	27.67 M GREAT
Average 1W Daily Value	21.72 M GREAT

Timing Factors

57%

MACD	SIGN IN
MACD Signal	SIGN IN
MACD Divergence	SIGN IN
RSI	SIGN IN
Stochastic Oscillator K	SIGN IN
Stochastic Oscillator D	SIGN IN
ADX	SIGN IN
Avg 5 day Timing Score	SIGN IN

Financial Health

50%

DE / Sector	SIGN IN
DE Average / Sector	SIGN IN
DE Change Average (%) / Sector	SIGN IN
Current Ratio / Sector	SIGN IN
Current Ratio Average / Sector	SIGN IN
Current Ratio Change Average (%) / Sector	SIGN IN
Quick Ratio / Sector	SIGN IN
Quick Ratio Average / Sector	SIGN IN
Quick Ratio Change Average (%) / Sector	SIGN IN
FCF/Share / Sector	SIGN IN
FCF/Share Average / Sector	SIGN IN
FCF/Share Change Average (%) / Sector	SIGN IN

Ability to Make Profit

56%

GPM (%) / Sector	SIGN IN
GPM Average (%) / Sector	SIGN IN
GPM Change Average (%) / Sector	SIGN IN
OPM (%) / Sector	SIGN IN
OPM Average (%) / Sector	SIGN IN
OPM Change Average (%) / Sector	SIGN IN
NPM (%) / Sector	-31.82 / 20.50
NPM Average (%) / Sector	-59.50 / -15.37
NPM Change Average (%) / Sector	-25.49 / 7.34
Asset Turnover / Sector	SIGN IN
Asset Turnover Average / Sector	SIGN IN
Asset Turnover Change Average (%) / Sector	SIGN IN
ROA (%) / Sector	-21.04 / 39.11
ROA Average (%) / Sector	-22.26 / 5.58
ROA Change Average (%) / Sector	-4.99 / 104.50
ROE (%) / Sector	-29.47 / -166.42
ROE Average (%) / Sector	-32.05 / -16.93
ROE Change Average (%) / Sector	-6.67 / -500.08
ROIC (%) / Sector	SIGN IN
ROIC Average (%) / Sector	SIGN IN
ROIC Change Average (%) / Sector	SIGN IN

Return to Investors

Dividend (%) / Sector	N/A / 0.43
Dividend Average (%) / Sector	N/A / 1.85
Dividend Change Average (%) / Sector	N/A / 3.44

Registration Details

Analyze Date	2026-08-01 08:00:20
Symbol	PRCT
Name	PROCEPT BIOROBOTICS CORP
Sector	Healthcare >> Medical Devices
Market	NASDAQ
Listed Shares	56.92 M
Par Value	N/A
Calculated From	Quarter
Sign	N/A
Market Cap (M.USD) / Sector Average	1,024.54 / 20,104.97

News, Concensus, ...

Estimation Consensus	See at WSJ.com
Full details	See at WSJ.com
Chart	See in Chart feature
News	See at Yahoo Finance

Address: 150 Baytech Drive, San Jose, CA, United States, 95134

Phone: 650 232 7200

Website: https://www.procept-biorobotics.com

Employees: 888

Sector: Healthcare >> Medical Devices

Description: PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology in the United States and internationally. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery focusing on treating benign prostatic hyperplasia. The company also provides HYDROS Robotic System, which provides Aquablation therapy image-guided robotic therapy to treat males suffering from lower urinary tract symptoms due to benign prostatic hyperplasia. PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in San Jose, California.